speb/financial-data huggingface dataset:
FHI balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 47574000.00
FHI balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 47574000.00
FHI balance_sheet (annual, 2025-12-31) — Gross PPE: 207586000.00
FHI balance_sheet (quarterly, 2025-12-31) — Gross PPE: 207586000.00
FHI income_statement (annual, 2025-12-31) — Gross Profit: 1222977000.00
FHI income_statement (quarterly, 2025-12-31) — Gross Profit: 337852000.00
FHI income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 13731000.00
FHI income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 3476000.00
FHI income_statement (annual, 2025-12-31) — Interest Expense: 12732000.00
FHI income_statement (quarterly, 2025-12-31) — Interest Expense: 3201000.00
FHI income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 12732000.00
FHI income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 3201000.00
FHI cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 11805000.00
FHI balance_sheet (annual, 2025-12-31) — Invested Capital: 1545317000.00
FHI balance_sheet (quarterly, 2025-12-31) — Invested Capital: 1545317000.00
FHI cash_flow (annual, 2025-12-31) — Investing Cash Flow: 2006000.00
FHI cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 14100000.00
FHI balance_sheet (annual, 2025-12-31) — Leases: 46813000.00
FHI balance_sheet (quarterly, 2025-12-31) — Leases: 46813000.00
FHI balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 88491000.00
FHI balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 88491000.00
FHI balance_sheet (annual, 2025-12-31) — Long Term Debt: 348369000.00
FHI balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 348369000.00
FHI balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 436860000.00
FHI balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 436860000.00
FHI balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 64980000.00
FHI balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 64980000.00
FHI balance_sheet (annual, 2025-12-31) — Minority Interest: 66529000.00
FHI balance_sheet (quarterly, 2025-12-31) — Minority Interest: 66529000.00
FHI income_statement (annual, 2025-12-31) — Minority Interests: -10796000.00
FHI income_statement (quarterly, 2025-12-31) — Minority Interests: -394000.00
FHI cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 10796000.00
FHI cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 13674000.00
FHI cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -262775000.00
FHI cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -77099000.00
FHI income_statement (annual, 2025-12-31) — Net Income: 403299000.00
FHI income_statement (quarterly, 2025-12-31) — Net Income: 107039000.00
FHI income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 385159000.00
FHI income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 102240000.00
FHI income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 414095000.00
FHI income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 107433000.00
FHI income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 403299000.00
FHI income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 107039000.00
FHI income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 403299000.00
FHI income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 107039000.00
FHI cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 414095000.00
FHI cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 107433000.00
FHI income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 414095000.00
FHI income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 107433000.00
FHI income_statement (annual, 2025-12-31) — Net Interest Income: -12732000.00
FHI income_statement (quarterly, 2025-12-31) — Net Interest Income: -3201000.00
FHI income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -12732000.00
FHI income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -3201000.00
FHI cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 129764000.00
FHI cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 4969000.00
FHI cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -6028000.00
FHI cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 0.00
FHI balance_sheet (annual, 2025-12-31) — Net PPE: 120631000.00
FHI balance_sheet (quarterly, 2025-12-31) — Net PPE: 120631000.00
FHI cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -2762000.00
FHI cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 426000.00
FHI balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 13336000.00
FHI balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 13336000.00
FHI balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 183542000.00
FHI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 183542000.00
FHI balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 183542000.00
FHI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 183542000.00
FHI income_statement (annual, 2025-12-31) — Normalized EBITDA: 549837000.00
FHI income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 144698000.00
FHI income_statement (annual, 2025-12-31) — Normalized Income: 378592164.00
FHI income_statement (quarterly, 2025-12-31) — Normalized Income: 103663632.32
FHI cash_flow (annual, 2025-12-31) — Operating Cash Flow: 297345000.00
FHI cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 161200000.00
FHI cash_flow (annual, 2025-12-31) — Operating Gains Losses: -164752000.00
FHI cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -6301000.00
FHI income_statement (annual, 2025-12-31) — Operating Income: 527613000.00
FHI income_statement (quarterly, 2025-12-31) — Operating Income: 139050000.00
FHI income_statement (annual, 2025-12-31) — Operating Revenue: 1800663000.00
FHI income_statement (quarterly, 2025-12-31) — Operating Revenue: 482833000.00
FHI balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 76395966.00
FHI balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 76395966.00
FHI balance_sheet (annual, 2025-12-31) — Other Current Assets: 12885000.00
FHI balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 12885000.00
FHI balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 18619000.00
FHI balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 18619000.00
FHI balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 6484000.00
FHI balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 6484000.00
FHI income_statement (annual, 2025-12-31) — Other Gand A: 179263000.00
FHI income_statement (quarterly, 2025-12-31) — Other Gand A: 48118000.00
FHI income_statement (annual, 2025-12-31) — Other Income Expense: 32645000.00
FHI income_statement (quarterly, 2025-12-31) — Other Income Expense: 4483000.00
FHI balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 331510000.00
FHI balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 331510000.00
FHI balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 61302000.00
FHI balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 61302000.00
FHI balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 31317000.00
FHI balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 31317000.00
FHI income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -36000.00
FHI income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 74000.00
FHI income_statement (annual, 2025-12-31) — Other Operating Expenses: 19029000.00
FHI income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 11640000.00
FHI balance_sheet (annual, 2025-12-31) — Other Properties: 95793000.00
FHI balance_sheet (quarterly, 2025-12-31) — Other Properties: 95793000.00
FHI balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 141755000.00
FHI balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 141755000.00
FHI income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 18140000.00
FHI income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 4799000.00
FHI balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 99046000.00
FHI balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 99046000.00
FHI balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 176329000.00
FHI balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 176329000.00
FHI balance_sheet (annual, 2025-12-31) — Prepaid Assets: 36832000.00
FHI balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 36832000.00
FHI income_statement (annual, 2025-12-31) — Pretax Income: 547526000.00
FHI income_statement (quarterly, 2025-12-31) — Pretax Income: 140332000.00
FHI balance_sheet (annual, 2025-12-31) — Properties: 0.00
FHI balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
FHI cash_flow (annual, 2025-12-31) — Purchase Of Business: -18692000.00
FHI cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -13084000.00
FHI cash_flow (annual, 2025-12-31) — Purchase Of PPE: -2762000.00
FHI cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: 426000.00
FHI balance_sheet (annual, 2025-12-31) — Receivables: 89778000.00
FHI balance_sheet (quarterly, 2025-12-31) — Receivables: 89778000.00
FHI income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 577686000.00
FHI income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 144981000.00
FHI income_statement (annual, 2025-12-31) — Reconciled Depreciation: 22260000.00
FHI income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 5574000.00
FHI income_statement (annual, 2025-12-31) — Rent And Landing Fees: 39695000.00
FHI income_statement (quarterly, 2025-12-31) — Rent And Landing Fees: 9704000.00
FHI income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 39695000.00
FHI income_statement (quarterly, 2025-12-31) — Rent Expense Supplemental: 9704000.00
FHI cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -262775000.00
FHI cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -77099000.00
FHI balance_sheet (annual, 2025-12-31) — Retained Earnings: 1531076000.00
FHI balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 1531076000.00
FHI cash_flow (annual, 2025-12-31) — Sale Of Business: 42243000.00
FHI cash_flow (quarterly, 2025-12-31) — Sale Of Business: 26758000.00
FHI income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 457377000.00
FHI income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 129340000.00
FHI income_statement (annual, 2025-12-31) — Selling General And Administration: 676335000.00
FHI income_statement (quarterly, 2025-12-31) — Selling General And Administration: 187162000.00
FHI balance_sheet (annual, 2025-12-31) — Share Issued: 99514456.00
FHI balance_sheet (quarterly, 2025-12-31) — Share Issued: 99514456.00
FHI income_statement (annual, 2025-12-31) — Special Income Charges: -13731000.00
FHI income_statement (quarterly, 2025-12-31) — Special Income Charges: -3476000.00
FHI cash_flow (annual, 2025-12-31) — Stock Based Compensation: 29130000.00
FHI cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 5952000.00
FHI balance_sheet (annual, 2025-12-31) — Stockholders Equity: 1196948000.00
FHI balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 1196948000.00
FHI balance_sheet (annual, 2025-12-31) — Tangible Book Value: 13336000.00
FHI balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 13336000.00
FHI income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 7974164.00
FHI income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 1033632.32
FHI income_statement (annual, 2025-12-31) — Tax Provision: 133431000.00
FHI income_statement (quarterly, 2025-12-31) — Tax Provision: 32899000.00
FHI income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.24
FHI income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.23
FHI balance_sheet (annual, 2025-12-31) — Total Assets: 2229337000.00
FHI balance_sheet (quarterly, 2025-12-31) — Total Assets: 2229337000.00
FHI balance_sheet (annual, 2025-12-31) — Total Capitalization: 1545317000.00
FHI balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 1545317000.00
FHI balance_sheet (annual, 2025-12-31) — Total Debt: 457007000.00
FHI balance_sheet (quarterly, 2025-12-31) — Total Debt: 457007000.00
FHI balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 1263477000.00
FHI balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 1263477000.00
FHI income_statement (annual, 2025-12-31) — Total Expenses: 1273050000.00
FHI income_statement (quarterly, 2025-12-31) — Total Expenses: 343783000.00
FHI balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 965860000.00
FHI balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 965860000.00
FHI balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 1365545000.00
FHI balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1365545000.00
FHI balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 651719000.00
FHI balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 651719000.00
FHI income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 513882000.00
FHI income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 135574000.00
FHI income_statement (annual, 2025-12-31) — Total Unusual Items: 32681000.00
FHI income_statement (quarterly, 2025-12-31) — Total Unusual Items: 4409000.00
FHI income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 32681000.00
FHI income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 4409000.00
FHI balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 23118490.00
FHI balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 23118490.00
FHI balance_sheet (annual, 2025-12-31) — Treasury Stock: 873214000.00
FHI balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 873214000.00
FHI cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -10794000.00
FHI cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 2936000.00
FHI balance_sheet (annual, 2025-12-31) — Working Capital: 549651000.00
FHI balance_sheet (quarterly, 2025-12-31) — Working Capital: 549651000.00
FHI income_statement (quarterly, 2026-03-31) — +Operating Expense: 195085000.00
FHI income_statement (quarterly, 2026-03-31) — +Total Revenue: 478957000.00
FHI balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 102179000.00
FHI balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 50336000.00
FHI balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -87208000.00
FHI balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -21000.00
FHI income_statement (quarterly, 2026-03-31) — Basic Average Shares: 72648000.00
FHI income_statement (quarterly, 2026-03-31) — Basic EPS: 1.27
FHI cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 584381000.00
FHI cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -4844000.00
FHI balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 102076000.00
FHI balance_sheet (quarterly, 2026-03-31) — Capital Stock: 544874000.00
FHI balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 513884000.00
FHI balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 645417000.00
FHI cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -25947000.00
FHI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -97248000.00
FHI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 1159000.00
FHI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 28848000.00
FHI cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 18282000.00
FHI cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -103145000.00
FHI cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 302000.00
FHI cash_flow (quarterly, 2026-03-31) — Change In Receivables: -4621000.00
FHI cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -89182000.00
FHI cash_flow (quarterly, 2026-03-31) — Changes In Cash: -67241000.00
FHI balance_sheet (quarterly, 2026-03-31) — Common Stock: 544874000.00
FHI cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -25947000.00
FHI balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1204320000.00
FHI cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -64721000.00
FHI income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 154119000.00
FHI balance_sheet (quarterly, 2026-03-31) — Current Assets: 788570000.00
FHI balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 18888000.00
FHI balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 18888000.00
FHI balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 240680000.00
FHI cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 1210000.00
FHI cash_flow (quarterly, 2026-03-31) — Deferred Tax: 1210000.00
FHI cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 5252000.00
FHI cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 5252000.00
FHI income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 72650000.00
FHI income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.27
FHI income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 91990000.00
FHI balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Current: 43361000.00
FHI income_statement (quarterly, 2026-03-31) — EBIT: 132954000.00
FHI income_statement (quarterly, 2026-03-31) — EBITDA: 138206000.00
FHI cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -2765000.00
FHI cash_flow (quarterly, 2026-03-31) — End Cash Position: 514375000.00
FHI cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -97248000.00
FHI cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 24004000.00
FHI cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of Business: 3763000.00
FHI income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 6653000.00
FHI balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -2418000.00
FHI income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 57861000.00
FHI balance_sheet (quarterly, 2026-03-31) — Goodwill: 848935000.00
FHI balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 1173986000.00
FHI balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 50357000.00
FHI balance_sheet (quarterly, 2026-03-31) — Gross PPE: 204731000.00
FHI income_statement (quarterly, 2026-03-31) — Gross Profit: 324838000.00
FHI income_statement (quarterly, 2026-03-31) — Impairment Of Capital Assets: 3422000.00
FHI balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 28606000.00
FHI income_statement (quarterly, 2026-03-31) — Interest Expense: 3185000.00
FHI income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 3185000.00
FHI balance_sheet (quarterly, 2026-03-31) — Invested Capital: 1552754000.00
FHI cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 1159000.00
FHI balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 83188000.00
FHI balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 348434000.00
FHI balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 431622000.00
FHI balance_sheet (quarterly, 2026-03-31) — Minority Interest: 58520000.00
FHI income_statement (quarterly, 2026-03-31) — Minority Interests: 432000.00
FHI cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 6003000.00
FHI cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -64721000.00
FHI income_statement (quarterly, 2026-03-31) — Net Income: 96378000.00
FHI income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 91990000.00
FHI income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 95946000.00
FHI income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 96378000.00
FHI income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 96378000.00
FHI cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 95946000.00
FHI income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 95946000.00
FHI income_statement (quarterly, 2026-03-31) — Net Interest Income: -3185000.00
FHI income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -3185000.00
FHI cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -6580000.00
FHI balance_sheet (quarterly, 2026-03-31) — Net PPE: 117523000.00
FHI cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -4844000.00
FHI balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 30334000.00
FHI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 184317000.00
FHI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 184317000.00
FHI income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 134975000.00
FHI income_statement (quarterly, 2026-03-31) — Normalized Income: 93990291.00
FHI cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 28848000.00
FHI cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 1487000.00
FHI income_statement (quarterly, 2026-03-31) — Operating Income: 129753000.00
FHI income_statement (quarterly, 2026-03-31) — Operating Revenue: 478957000.00
FHI balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 75528013.00
FHI balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 12769000.00
FHI balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 18801000.00
FHI balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -2418000.00
FHI income_statement (quarterly, 2026-03-31) — Other Gand A: 47799000.00
FHI income_statement (quarterly, 2026-03-31) — Other Income Expense: 3201000.00
FHI balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 325051000.00
FHI balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 63728000.00
FHI balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 24348000.00
FHI income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -30000.00
FHI income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 7381000.00
FHI balance_sheet (quarterly, 2026-03-31) — Other Properties: 204731000.00
FHI balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 131533000.00
FHI income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 4388000.00
FHI balance_sheet (quarterly, 2026-03-31) — Payables: 130785000.00
FHI balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 130785000.00
FHI balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 72206000.00
FHI balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 36687000.00
FHI income_statement (quarterly, 2026-03-31) — Pretax Income: 129769000.00
FHI cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -1403000.00
FHI cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -4844000.00
FHI balance_sheet (quarterly, 2026-03-31) — Receivables: 93697000.00
FHI income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 154119000.00
FHI income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 5252000.00
FHI income_statement (quarterly, 2026-03-31) — Rent And Landing Fees: 10062000.00
FHI income_statement (quarterly, 2026-03-31) — Rent Expense Supplemental: 10062000.00
FHI cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -64721000.00
FHI balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 1591369000.00
FHI cash_flow (quarterly, 2026-03-31) — Sale Of Business: 7406000.00
FHI income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 129843000.00
FHI income_statement (quarterly, 2026-03-31) — Selling General And Administration: 187704000.00
FHI balance_sheet (quarterly, 2026-03-31) — Share Issued: 99514456.00
FHI income_statement (quarterly, 2026-03-31) — Special Income Charges: -3422000.00
FHI cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 12272000.00
FHI balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1204320000.00
FHI balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 30334000.00
FHI income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 843291.00
FHI income_statement (quarterly, 2026-03-31) — Tax Provision: 33823000.00
FHI income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.26
FHI balance_sheet (quarterly, 2026-03-31) — Total Assets: 2143807000.00
FHI balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 1552754000.00
FHI balance_sheet (quarterly, 2026-03-31) — Total Debt: 450510000.00
FHI balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1262840000.00
FHI income_statement (quarterly, 2026-03-31) — Total Expenses: 349204000.00
FHI balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 880967000.00
FHI balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1355237000.00
FHI balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 640287000.00
FHI income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 126331000.00
FHI balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 28606000.00
FHI income_statement (quarterly, 2026-03-31) — Total Unusual Items: 3231000.00
FHI income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 3231000.00
FHI balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 23986443.00
FHI balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 929505000.00
FHI cash_flow (quarterly, 2026-03-31) — Unrealized Gain Loss On Investment Securities: 1863000.00
FHI balance_sheet (quarterly, 2026-03-31) — Working Capital: 547890000.00
FHN cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: 0.00
FHN cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: 29000000.00
FHN income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 34000000.00
FHN cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 145000000.00
FHN cash_flow (annual, 2021-12-31) — Long Term Debt Payments: -108000000.00
FHN cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 0.00
FHN cash_flow (annual, 2021-12-31) — Net Preferred Stock Issuance: 145000000.00
FHN income_statement (annual, 2021-12-31) — Other Gand A: 37000000.00
FHN balance_sheet (annual, 2021-12-31) — Other Properties: 16000000.00
FHN income_statement (annual, 2021-12-31) — Other Special Charges: 1000000.00
FHN cash_flow (annual, 2021-12-31) — Preferred Stock Issuance: 145000000.00
FHN cash_flow (annual, 2021-12-31) — Repayment Of Debt: -108000000.00
FHN income_statement (annual, 2021-12-31) — Restructuring And Mergern Acquisition: 0.00
FHN cash_flow (annual, 2021-12-31) — Sale Of Business: 0.00
FHN cash_flow (annual, 2021-12-31) — Short Term Debt Payments: -75000000.00
FHN cash_flow (annual, 2021-12-31) — Unrealized Gain Loss On Investment Securities: 1824000000.00
FHN income_statement (annual, 2022-12-31) — +Total Revenue: 3120000000.00
FHN balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -455000000.00
FHN balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 4840000000.00
FHN income_statement (annual, 2022-12-31) — Amortization: 51000000.00
FHN cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 26000000.00
FHN cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 26000000.00
FHN income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 51000000.00
FHN income_statement (annual, 2022-12-31) — Basic Average Shares: 535000000.00
FHN income_statement (annual, 2022-12-31) — Basic EPS: 1.62
FHN cash_flow (annual, 2022-12-31) — Beginning Cash Position: 1788000000.00
FHN balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 544000000.00
FHN cash_flow (annual, 2022-12-31) — Capital Expenditure: -28000000.00
FHN balance_sheet (annual, 2022-12-31) — Capital Stock: 1350000000.00
FHN balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 2445000000.00
FHN balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 2927000000.00
FHN cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -356000000.00
FHN balance_sheet (annual, 2022-12-31) — Cash Financial: 1061000000.00
FHN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -10869000000.00
FHN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 8333000000.00
FHN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 2291000000.00
FHN cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 2644000000.00
FHN cash_flow (annual, 2022-12-31) — Change In Working Capital: 2644000000.00
FHN cash_flow (annual, 2022-12-31) — Changes In Cash: -245000000.00
FHN balance_sheet (annual, 2022-12-31) — Common Stock: 336000000.00
FHN cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -324000000.00
FHN balance_sheet (annual, 2022-12-31) — Common Stock Equity: 7238000000.00
FHN cash_flow (annual, 2022-12-31) — Common Stock Payments: -12000000.00
FHN balance_sheet (annual, 2022-12-31) — Current Debt: 1093000000.00
FHN balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 1093000000.00
FHN cash_flow (annual, 2022-12-31) — Deferred Income Tax: 91000000.00
FHN cash_flow (annual, 2022-12-31) — Deferred Tax: 91000000.00
FHN cash_flow (annual, 2022-12-31) — Depreciation: 59000000.00
FHN cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 85000000.00
FHN income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 51000000.00
FHN cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 85000000.00
FHN income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 51000000.00
FHN income_statement (annual, 2022-12-31) — Diluted Average Shares: 566000000.00
FHN income_statement (annual, 2022-12-31) — Diluted EPS: 1.53
FHN income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 868000000.00
FHN cash_flow (annual, 2022-12-31) — End Cash Position: 1543000000.00
FHN cash_flow (annual, 2022-12-31) — Financing Cash Flow: -10869000000.00
FHN cash_flow (annual, 2022-12-31) — Free Cash Flow: 2263000000.00
FHN cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -18000000.00
FHN cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
FHN cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -1000000.00
FHN income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 223000000.00
FHN balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -1368000000.00
FHN income_statement (annual, 2022-12-31) — General And Administrative Expense: 1187000000.00
FHN balance_sheet (annual, 2022-12-31) — Goodwill: 1511000000.00
FHN balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 1745000000.00
FHN balance_sheet (annual, 2022-12-31) — Gross PPE: 1067000000.00
FHN balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 1371000000.00
FHN income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
FHN cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 20000000.00
FHN income_statement (annual, 2022-12-31) — Insurance And Claims: 32000000.00
FHN income_statement (annual, 2022-12-31) — Interest Expense: 291000000.00
FHN income_statement (annual, 2022-12-31) — Interest Income: 2683000000.00
FHN cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 280000000.00
FHN balance_sheet (annual, 2022-12-31) — Invested Capital: 9928000000.00
FHN cash_flow (annual, 2022-12-31) — Investing Cash Flow: 8333000000.00
FHN balance_sheet (annual, 2022-12-31) — Investments And Advances: 11582000000.00
FHN cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 494000000.00
FHN cash_flow (annual, 2022-12-31) — Issuance Of Debt: 4000000.00
FHN balance_sheet (annual, 2022-12-31) — Land And Improvements: 163000000.00
FHN balance_sheet (annual, 2022-12-31) — Leases: 82000000.00
FHN balance_sheet (annual, 2022-12-31) — Long Term Debt: 1597000000.00
FHN balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 1597000000.00
FHN cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 4000000.00
FHN balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 277000000.00
FHN balance_sheet (annual, 2022-12-31) — Minority Interest: 295000000.00
FHN income_statement (annual, 2022-12-31) — Minority Interests: -12000000.00
FHN cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
FHN cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -12000000.00
FHN balance_sheet (annual, 2022-12-31) — Net Debt: 245000000.00
FHN income_statement (annual, 2022-12-31) — Net Income: 900000000.00
FHN income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 868000000.00
FHN income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 912000000.00
FHN income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 900000000.00
FHN income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 900000000.00
FHN cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 912000000.00
FHN income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 912000000.00
FHN income_statement (annual, 2022-12-31) — Net Interest Income: 2392000000.00
FHN cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -2073000000.00
FHN cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 386000000.00
FHN cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 4000000.00
FHN cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -11000000.00
FHN cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 97000000.00
FHN balance_sheet (annual, 2022-12-31) — Net PPE: 612000000.00
FHN cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -10000000.00
FHN cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 494000000.00
FHN cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 382000000.00
FHN balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 6507000000.00
FHN income_statement (annual, 2022-12-31) — Normalized Income: 900000000.00
FHN income_statement (annual, 2022-12-31) — Occupancy And Equipment: 286000000.00
FHN cash_flow (annual, 2022-12-31) — Operating Cash Flow: 2291000000.00
FHN cash_flow (annual, 2022-12-31) — Operating Gains Losses: -19000000.00
FHN income_statement (annual, 2022-12-31) — Operating Revenue: 3120000000.00
FHN balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 537100615.00
FHN balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 1093000000.00
FHN balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -1368000000.00
FHN balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 234000000.00
FHN cash_flow (annual, 2022-12-31) — Other Non Cash Items: -1592000000.00
FHN income_statement (annual, 2022-12-31) — Other Non Interest Expense: 230000000.00
FHN balance_sheet (annual, 2022-12-31) — Other Properties: 1000000.00
FHN balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 8836000000.00
FHN income_statement (annual, 2022-12-31) — Other Special Charges: 7000000.00
FHN balance_sheet (annual, 2022-12-31) — Preferred Shares Number: 21500000.00
FHN balance_sheet (annual, 2022-12-31) — Preferred Stock: 1014000000.00
FHN cash_flow (annual, 2022-12-31) — Preferred Stock Dividend Paid: -32000000.00
FHN income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 32000000.00
FHN balance_sheet (annual, 2022-12-31) — Preferred Stock Equity: 1014000000.00
FHN cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 494000000.00
FHN income_statement (annual, 2022-12-31) — Pretax Income: 1159000000.00
FHN cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 36000000.00
FHN income_statement (annual, 2022-12-31) — Professional Expense And Contract Services Expense: 62000000.00
FHN cash_flow (annual, 2022-12-31) — Purchase Of Investment: -3479000000.00
FHN cash_flow (annual, 2022-12-31) — Purchase Of PPE: -28000000.00
FHN income_statement (annual, 2022-12-31) — Reconciled Depreciation: 85000000.00
FHN cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -12000000.00
FHN income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 0.00
FHN balance_sheet (annual, 2022-12-31) — Retained Earnings: 3430000000.00
FHN income_statement (annual, 2022-12-31) — Salaries And Wages: 1155000000.00
FHN cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
FHN cash_flow (annual, 2022-12-31) — Sale Of Investment: 1406000000.00
FHN cash_flow (annual, 2022-12-31) — Sale Of PPE: 18000000.00
FHN income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 50000000.00
FHN income_statement (annual, 2022-12-31) — Selling General And Administration: 1237000000.00
FHN balance_sheet (annual, 2022-12-31) — Share Issued: 537100615.00
FHN cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 382000000.00
FHN income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
FHN cash_flow (annual, 2022-12-31) — Stock Based Compensation: 75000000.00
FHN balance_sheet (annual, 2022-12-31) — Stockholders Equity: 8252000000.00
FHN balance_sheet (annual, 2022-12-31) — Tangible Book Value: 5493000000.00
FHN income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
FHN income_statement (annual, 2022-12-31) — Tax Provision: 247000000.00
FHN income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
FHN balance_sheet (annual, 2022-12-31) — Total Assets: 78953000000.00
FHN balance_sheet (annual, 2022-12-31) — Total Capitalization: 9849000000.00
FHN balance_sheet (annual, 2022-12-31) — Total Debt: 2690000000.00
FHN balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 8547000000.00
FHN balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 70406000000.00
FHN income_statement (annual, 2022-12-31) — Total Unusual Items: 0.00
FHN income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 0.00
FHN balance_sheet (annual, 2022-12-31) — Trading Securities: 1375000000.00
FHN income_statement (annual, 2023-12-31) — +Total Revenue: 3155000000.00
FHN balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -506000000.00
FHN balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 5351000000.00
FHN income_statement (annual, 2023-12-31) — Amortization: 47000000.00
FHN cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 47000000.00
FHN cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 47000000.00
FHN income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 47000000.00
FHN income_statement (annual, 2023-12-31) — Basic Average Shares: 548000000.00
FHN income_statement (annual, 2023-12-31) — Basic EPS: 1.58
FHN cash_flow (annual, 2023-12-31) — Beginning Cash Position: 1543000000.00
FHN balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 554000000.00
FHN cash_flow (annual, 2023-12-31) — Capital Expenditure: -37000000.00
FHN balance_sheet (annual, 2023-12-31) — Capital Stock: 869000000.00
FHN balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 2340000000.00
FHN balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 3059000000.00
FHN cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -367000000.00
FHN balance_sheet (annual, 2023-12-31) — Cash Financial: 1012000000.00
FHN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 1494000000.00
FHN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -2605000000.00
FHN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 1299000000.00
FHN cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 849000000.00
FHN cash_flow (annual, 2023-12-31) — Change In Working Capital: 849000000.00
FHN cash_flow (annual, 2023-12-31) — Changes In Cash: 188000000.00
FHN balance_sheet (annual, 2023-12-31) — Common Stock: 349000000.00
FHN cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -335000000.00
FHN balance_sheet (annual, 2023-12-31) — Common Stock Equity: 8476000000.00
FHN cash_flow (annual, 2023-12-31) — Common Stock Payments: -10000000.00
FHN balance_sheet (annual, 2023-12-31) — Current Debt: 326000000.00
FHN balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 326000000.00
FHN cash_flow (annual, 2023-12-31) — Deferred Income Tax: 44000000.00
FHN cash_flow (annual, 2023-12-31) — Deferred Tax: 44000000.00
FHN cash_flow (annual, 2023-12-31) — Depreciation: 55000000.00
FHN cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 102000000.00
FHN income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 47000000.00
FHN cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 102000000.00
FHN income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 47000000.00
FHN income_statement (annual, 2023-12-31) — Diluted Average Shares: 562000000.00
FHN income_statement (annual, 2023-12-31) — Diluted EPS: 1.54
FHN income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 865000000.00
FHN cash_flow (annual, 2023-12-31) — End Cash Position: 1731000000.00
FHN cash_flow (annual, 2023-12-31) — Financing Cash Flow: 1494000000.00
FHN cash_flow (annual, 2023-12-31) — Free Cash Flow: 1262000000.00
FHN cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 4000000.00
FHN cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: -9000000.00
FHN cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 0.00
FHN income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 129000000.00
FHN balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -1188000000.00
FHN income_statement (annual, 2023-12-31) — General And Administrative Expense: 1271000000.00
FHN balance_sheet (annual, 2023-12-31) — Goodwill: 1510000000.00
FHN balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 1696000000.00
FHN balance_sheet (annual, 2023-12-31) — Gross PPE: 1096000000.00
FHN balance_sheet (annual, 2023-12-31) — Held To Maturity Securities: 1323000000.00
FHN income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
FHN cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 123000000.00
FHN income_statement (annual, 2023-12-31) — Insurance And Claims: 122000000.00
FHN income_statement (annual, 2023-12-31) — Interest Expense: 1560000000.00
FHN income_statement (annual, 2023-12-31) — Interest Income: 4100000000.00
FHN cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 1428000000.00
FHN balance_sheet (annual, 2023-12-31) — Invested Capital: 9952000000.00
FHN cash_flow (annual, 2023-12-31) — Investing Cash Flow: -2605000000.00
FHN balance_sheet (annual, 2023-12-31) — Investments And Advances: 11126000000.00
FHN cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
FHN cash_flow (annual, 2023-12-31) — Issuance Of Debt: 1000000.00
FHN balance_sheet (annual, 2023-12-31) — Land And Improvements: 163000000.00
FHN balance_sheet (annual, 2023-12-31) — Leases: 84000000.00
FHN balance_sheet (annual, 2023-12-31) — Long Term Debt: 1150000000.00
FHN balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 1150000000.00
FHN cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 1000000.00
FHN cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -450000000.00
FHN balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 295000000.00
FHN balance_sheet (annual, 2023-12-31) — Minority Interest: 295000000.00
FHN income_statement (annual, 2023-12-31) — Minority Interests: -19000000.00
FHN cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 11000000.00
FHN cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -10000000.00
FHN income_statement (annual, 2023-12-31) — Net Income: 897000000.00
FHN income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 865000000.00
FHN income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 916000000.00
FHN income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 897000000.00
FHN income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 897000000.00
FHN cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 916000000.00
FHN income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 916000000.00
FHN income_statement (annual, 2023-12-31) — Net Interest Income: 2540000000.00
FHN cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 648000000.00
FHN cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -406000000.00
FHN cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -449000000.00
FHN cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -17000000.00
FHN cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 30000000.00
FHN balance_sheet (annual, 2023-12-31) — Net PPE: 590000000.00
FHN cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -36000000.00
FHN cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 0.00
FHN cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 43000000.00
FHN balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 7300000000.00
FHN income_statement (annual, 2023-12-31) — Normalized Income: 714300000.00
FHN income_statement (annual, 2023-12-31) — Occupancy And Equipment: 234000000.00
FHN cash_flow (annual, 2023-12-31) — Operating Cash Flow: 1299000000.00
FHN cash_flow (annual, 2023-12-31) — Operating Gains Losses: 4000000.00
FHN income_statement (annual, 2023-12-31) — Operating Revenue: 3155000000.00
FHN balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 558838694.00
FHN balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 326000000.00
FHN balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -1188000000.00
FHN balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 186000000.00
FHN cash_flow (annual, 2023-12-31) — Other Non Cash Items: -912000000.00
FHN income_statement (annual, 2023-12-31) — Other Non Interest Expense: 320000000.00
FHN balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 8391000000.00
FHN income_statement (annual, 2023-12-31) — Other Special Charges: -225000000.00
FHN balance_sheet (annual, 2023-12-31) — Preferred Shares Number: 21480000.00
FHN balance_sheet (annual, 2023-12-31) — Preferred Stock: 520000000.00
FHN cash_flow (annual, 2023-12-31) — Preferred Stock Dividend Paid: -32000000.00
FHN income_statement (annual, 2023-12-31) — Preferred Stock Dividends: 32000000.00
FHN balance_sheet (annual, 2023-12-31) — Preferred Stock Equity: 520000000.00
FHN cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 0.00
FHN income_statement (annual, 2023-12-31) — Pretax Income: 1128000000.00
FHN cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 5000000.00
FHN income_statement (annual, 2023-12-31) — Professional Expense And Contract Services Expense: 49000000.00
FHN cash_flow (annual, 2023-12-31) — Purchase Of Investment: -261000000.00